The agreement sets terms under which POC will manufacture the product or receive royalties
Microdosing has emerged as a key trend in the pharmaceutical and nutritional markets
Long COVID is a debilitating chronic condition that has affected over 100 million people globally
PrecisionLife to analyse OXEGENE data to improve mechanistic understanding of endometriosis and identify novel drug targets to support the development of new personalised treatments
Collaboration to provide hospitals with a comprehensive offering across imaging and treatment for cancer patients requiring radiation therapy
Collaboration to accelerate and de-risk clinical development of Nanopharmaceutics CNS portfolio
Bridging the gap between histopathology and molecular pathology
Dr. Hubbard brings more than 35 years of experience in the biopharmaceutical and pharma-tech services industries and CROs.
APAC region contributed around 50% of the in-vitro diagnostics market in 2022
Coordinated by the Medical University of Vienna, a consortium of 13 leading European organizations including university hospitals, research institutions and healthcare companies will conduct the 5-year project co-funded by Horizon Europe.
Subscribe To Our Newsletter & Stay Updated
